0000064803-18-000007.txt : 20180206 0000064803-18-000007.hdr.sgml : 20180206 20180205173947 ACCESSION NUMBER: 0000064803-18-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180205 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 18575415 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 cvs-20180205x8k.htm 8-K cvs_Folio_8K_02052018

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 5, 2018

 

Image - Image1.gif

CVS HEALTH CORPORATION

(Exact Name of Registrant

as Specified in its Charter)

 

 

 

 

 

Delaware

 

 

(State or Other Jurisdiction of Incorporation)

 

 

 

 

001-01011

 

05-0494040

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

One CVS Drive

 

Woonsocket, Rhode Island

02895

(Address of Principal Executive Offices)

(Zip Code)

 

Registrant’s telephone number, including area code:  (401) 765-1500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b) On February 5, 2018, CVS Health Corporation (the “Registrant”) announced that Helena B. Foulkes, Executive Vice President, CVS Health Corporation and President – CVS Pharmacy, will be leaving employment with the Registrant and its subsidiaries effective February 9, 2018.

 

2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

CVS HEALTH CORPORATION

 

 

 

By:

/s/ Colleen M. McIntosh

 

 

Colleen M. McIntosh

 

 

Senior Vice President and Corporate Secretary

 

 

 

 

 

Dated:   February 5, 2018

 

 

3

GRAPHIC 2 cvs20180205x8k001.gif GRAPHIC begin 644 cvs20180205x8k001.gif M1TE&.#EAI0 R /< /\ _P ,$!0 (" @)"@L,#0@0$ \0$1,4%187&!P= M'B$B(B$A*2@I*3$R,S@Y.CE".3T^/D%"0T)"2D)*2DA)24I*4D]045Q<76-D M9&QL;6YO<&]P<'-T=7=X>7EZ>G^ @(.$A8B(B8R,C)66EI2GJ"AH:6F MIJFIJJ6MK:RMK;6UM;N\O+V]QL< \7%Q*]$B+](H--,K.-0O.]0S/]4W0]8\1]= 3-;6SM?7 MU]Y"2MA&4=E*5=I-5]M16]Q57]Q:8]Y::]YA:]]H<=[>WM[GY^!K=.%R>^-X M?^-[@^2 A^6$B^:)D.B/E>7EY>^,E.F6G.F9G^J=H^REJNVLL.ZOM.^RMN^W MN^[N[O>UO?&]P/&_PO+#Q_/)S/3.T/71U/75V/?9V_?>X/GY^?_>WOGFY__G M[_OM[OWW]_[^_@ M M M M M M M M M "'_"TY%5%-#05!%,BXP P$! A^00! "P M I0 R (_P#M"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(L:/' MCR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMR)TTH2*P>Q* &ZD(Z7 M)TN4-,&B9J"<-5"ARBE81TU4-5/M&(6R)$D3*V@,YAA+MB#9LAUAC#62,,I8 M&!UYS*@Q@T=!'S+HXDA8A\B+N34"S\@;QDZ;%S(2OR!2$ MBQ6_L^ 4L6,8, M, 0#:-Y<<#/GCIL7))2PNV+AOV'A!Q8[N MV#,*!JFA>K8=NKEC[[XR\$,'S1Y"% SQ0;.&#QY'9 C@("&+$9I-9__\ 1OW M#"!VAI2/S;H@'1DVDN=^0<;*>AE9!;X KJ7)>ALSS(7;"Y$-I%E"!X($ W<# MY:# !9T%(-Y%0:R'6V#$)3?##P0-9]Y-.1JTXT<]=B=0#@$T$.&$%?40'Y)( MCBC0%.O-0)1 =;R H9]6I*9:< +MD.$,5-@66PU*$"3'I).B&0""0Q+$0@4) M$- =@?!P.D!$K!@1PX=@-!!%':T:<<6'VS_E\ (JPIT( P2''! !3E(Y,.= M>,JGIQT^5"E#'<+QT$,/.S01)HL%.FGE&W1(*]L+/US!!D(X7HK0F@(MX-EF M*Q1$VK@2H+"9J:["&0 !Z]H:P';C=A#1%]8&BYL,6 A4PYTVV-#0OX>B"(:7 M-0B$0Y7%#39#$FL4U&T(%%=,,7B9VG% G&P)I(%FO0IT+@H#;0>O!%' T2J# M<.1@0@ +;)&#RG8$(,"\ ZD;0 L1/6&DOE8N,=!Z-;3&T!.&UK!E$QG2,(5 M:PAZ9 TO+"E0M^-F+5YUO[*;:<488LI 3)6$ADC,P1A#@\3ET7]\B(DH0&4HXS/ -+R!K1[>8FK;% MNPAA$ )-0< N= M@,'!]0E]N/O6D,J@P0@-CR#/2>'F5J@\@[B0(N3)37L20J5]W8 \.K02098P M.QI8K4G[(L(4EF"A%V0EB3K*U,T^1Q XE$%EI,G 0> EQ8%0<8-6'-M%?$ T MVBCD#?D:46YD0,$Q_$P&81G(#QA6 QI0DGORPA3-P#.W@HCM39KIV$ X8+:! ML"!M/;I?\&A&D )DK"(\2$T-]L(0,4CM2#(8@D'R)0.J"&AJ,J"#0%#PL@"@ M@&0$68'.2(!,<1V 9[<+@6:@:0??!4 $*MM"!0* @ \H 6ZTPP+X+*[ *0@ M!V7(08^,"1>!&*$%\#I!.RV" ]@\Q T[L(P!!?/' @H.9#)#C!15?O 7@HUH M!B_H@3#EY9D(-50@E,L:-05B3<]@0'[B%(@#/A.!S8C*,V 3"+TT0X",3"\B M;+ "$G[0 R$T(4H(>0,8PD!3,!3((&WP"1!X$(2?;(L@QPQJN9(9U&,2Q @= MJ, #,%#"@VRA Q*(@ ;8$H5CFL!Y=D!!!T9@2N>4 09%-=6;PLJ3LIKUK&A- MJUK7RM:VNO6M<(VK7.=*U[K:]:YXS:M>]\K7OOKUKX -K& '2]C"&O:PB$VL &8LT:$ [ end